121 related articles for article (PubMed ID: 2415971)
21. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
[TBL] [Abstract][Full Text] [Related]
22. A survey on the effect of steroid hormone on type C virus production from cultured murine cells.
Wu AM; Richardson LS; Paran M; Gallo RC
Cancer Res; 1976 Jun; 36(6):2025-30. PubMed ID: 178441
[TBL] [Abstract][Full Text] [Related]
23. Isolation of a B-tropic type-C virus from reticulum cell neoplasms induced in BALB/c mice by SJL/J type-C virus.
Chang KS; Aoki T; Law LW
J Natl Cancer Inst; 1975 Jan; 54(1):83-7. PubMed ID: 163327
[TBL] [Abstract][Full Text] [Related]
24. Effects of murine leukemia viruses on the function of dendritic cells.
Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
[TBL] [Abstract][Full Text] [Related]
25. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
Allen PT; Schellekens H; Van Griensven LJ; Billiau A
J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
Schenk PJ; Howe ML
J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
[TBL] [Abstract][Full Text] [Related]
27. In vivo analysis of castanospermine, a candidate antiretroviral agent.
Ruprecht RM; Mullaney S; Andersen J; Bronson R
J Acquir Immune Defic Syndr (1988); 1989; 2(2):149-57. PubMed ID: 2495348
[TBL] [Abstract][Full Text] [Related]
28. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
29. Rauscher viral leukemogenesis in BALB/c mice treated with rabbit antimouse thymocyte serum.
Siegel BV; Morton JI
J Natl Cancer Inst; 1970 Mar; 44(3):573-9. PubMed ID: 11515425
[No Abstract] [Full Text] [Related]
30. Inhibition of human immunodeficiency virus type I reverse transcriptase by suramin-related compounds.
Jentsch KD; Hunsmann G; Hartmann H; Nickel P
J Gen Virol; 1987 Aug; 68 ( Pt 8)():2183-92. PubMed ID: 2440983
[TBL] [Abstract][Full Text] [Related]
31. Murine leukaemia virus infections as models for retroviral disease in humans.
Roberts MS; Harvey JJ; Macatonia SE; Knight SC
Adv Exp Med Biol; 1993; 329():533-7. PubMed ID: 8397476
[No Abstract] [Full Text] [Related]
32. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
Sinkovics JG
Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
[TBL] [Abstract][Full Text] [Related]
33. Suramin in the treatment of AIDS: mechanism of action.
De Clercq E
Antiviral Res; 1987 Jan; 7(1):1-10. PubMed ID: 2432836
[TBL] [Abstract][Full Text] [Related]
34. Effects of streptovaricins and their degradation products on infectivity of Rauscher leukemia virus.
Li LH; Clark TD; Cowie CH; Swenberg JA; Renis HE; Rinehart KL
J Natl Cancer Inst; 1977 Feb; 58(2):245-9. PubMed ID: 64616
[TBL] [Abstract][Full Text] [Related]
35. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of urethane leukaemia virus, a murine retrovirus, in mice by zidovudine.
Harvey JJ; Tuffrey M; Wedderburn N; Alexander F; Curtis J; Taylor-Robinson D; Doré C
Int J STD AIDS; 1990 Sep; 1(5):349-56. PubMed ID: 1965887
[TBL] [Abstract][Full Text] [Related]
37. In search of specific inhibitors of retrovirus replication.
De Clercq E; Balzarini J
Antiviral Res; 1985; Suppl 1():89-94. PubMed ID: 2417552
[No Abstract] [Full Text] [Related]
38. Interactions between differentiation and leukaemogenesis in Rauscher murine leukaemia.
Brommer EJ; Bentvelzen P
Bibl Haematol; 1973; 39():929-34. PubMed ID: 4778005
[No Abstract] [Full Text] [Related]
39. Effective treatment of murine leukemia with antisense poly-2'O-(2,4-dinitrophenyl)-oligoribonucleotides.
Wang A; Wang JH
Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):43-51. PubMed ID: 10192288
[TBL] [Abstract][Full Text] [Related]
40. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
